• Insulin glargine is a man-made form of a hormone that is produced in the body.
  • Read all of this leaflet carefully including the Instructions for Use of Lantus SoloStar, pre- filled pen, before you start using this medicine because it contains important information for you.
  • This leaflet answers some common questions about Lantus.It does not contain all the available information.
  • Lantus is a solution for injection containing insulin glargine.Insulin glargine is a modified insulin, very similar to human insulin.
  • The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.
  • Do not take Lantus
  • Insulin glargine is a long acting analogue insulin Lantus is an analogue insulin produced by Sanofi-Aventis with the medical name insulin glargine.
  • BASAGLAR is a long-acting insulin with an identical amino acid sequence to Lantus(R), another U-100 insulin glargine.
  • BASAGLAR is a long-acting insulin with an identical amino acid sequence to Lantus
  • Lantus(R) is a brand name for insulin glargine, a long acting insulin used for the treatment of type 1 diabetes mellitus (insulin dependent, IDDM) and type 2 diabetes mellitus (noninsulin dependent, NIDDM) requiring basal (long-acting) insulin to improve ...
  • 1 2 3 4 5 6 7 8 9


    Soliqua 100/33 (insulin glargine/lixisenatide) Soliqua 100/33 (insulin glargine/lixisenatide) is a brand-name prescription medication that's used with diet and exercise to improve blood sugar levels in adults with type 2 diabetes. It comes as a pen that y
    Medical News Today - Wednesday, September 18, 2019
    Toujeo (insulin glargine) Toujeo is a brand-name prescription medication that's used to treat type 1 and type 2 diabetes. It contains insulin glargine, which is a long-acting insulin. Toujeo is injected under the skin (subcutaneous). Learn about side effe
    Medical News Today - Friday, September 6, 2019
    Mylan and Biocon Hit With Second CRL for Insulin Glargine Biosimilar
    U.S. Food and Drug Administration - Friday, September 6, 2019
    Lantus (insulin glargine) Lantus (insulin glargine) is a brand-name prescription medication. It's used to improve blood sugar levels in adults and children (ages 6 years and older) with type 1 diabetes, as well as adults with type 2 diabetes. Lantus is gi
    Medical News Today - Saturday, August 31, 2019
    AskNadia: Levemir vs. Lantus Dosing
    Diabetes Health - Sunday, November 11, 2018
    AskNadia: Substituting Lantus Insulin for Levemir
    Diabetes Health - Tuesday, October 23, 2018
    Insulin Glargine 300 Safe, Effective in Seniors With T2DM
    Physicians Briefing - Wednesday, June 27, 2018
    Tresiba(R) demonstrated significantly improved blood sugar control and lower rates of hypoglycemia versus insulin Toujeo(R) in real-world evidence study
    Newswire - Monday, June 25, 2018
    Mylan and Biocon Receive Approvals from the European Commission and TGA Australia for Semglee(TM), Biosimilar Insulin Glargine
    PR Newswire - Wednesday, March 28, 2018
    FDA Approves New, Larger Toujeo Pen
    P&T Community - Wednesday, March 28, 2018
    Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure HospitalizationThe ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
    American Heart Association - Monday, January 8, 2018
    EndoBreak: 2018 Diabetes Care Standard; Toujeo Trial Success
    Medpage Today - Monday, December 18, 2017
    The results of a recent study favour Toujeo(R) over degludec and real-world evidence confirms Toujeo(R)'s value
    Newswire - Wednesday, December 13, 2017
    Sanofi Files Patent Infringement Suit Against Mylan Over Lantus Generic
    U.S. Food and Drug Administration - Monday, October 30, 2017
    Sanofi Files Suit in the U.S. to Defend Its Patent Rights on Lantus(R) and Lantus(R) SoloStar(R)
    EIN News - Wednesday, October 25, 2017
    Soliqua (Insulin Glargine and Lixisenatide) Injection, for Subcutaneous Use
    RXList - Wednesday, October 11, 2017
    Long-term insulin glargine use may increase breast cancer risk
    Medwirenews - Thursday, October 5, 2017
    Sanofi Files Suit in the U.S. to Defend its Patent Rights on Lantus(R)
    EIN News - Wednesday, August 9, 2017


    About Diabetes and Insulin - Video
  • The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records.

  • Lantus Side Effects! ; With Better Options!
    Click on the link below for a free video guide to dietary supplements and herbal medicine! In this video I want to share some of the worst side effects of the drug Lantus, as well as give you a few other options. Today, di...

    Lantus - Medication Information
    Lantus, a brand name for insulin glargine, is a prescription medication used to treat type 1 and type 2 diabetes

    Is Insomnia a Side Effect of Lantus?
    I'm insulin-dependent diabetic on insulin 7 units once a day. If I take my Lantus at night, I have insomnia. If I take it in the morning, I sleep well. I can't find any information that insomnia is a side effect of Lantus. Do you know of any studies?...

    Lantus 3 Times a Week Treats Diabetes 2 Without Weight Gain
    Dr. Joe talks about using small amounts of Lantus to control metabolic problems.

    More Potent Diabetes Rx Approved
     Diabetes patients just got a more potent insulin option. That new option is Sanofi's Toujeo. The US Food and Drug Administration approved it Wednesday. Toujeo may carry a lower risk of hypoglycemia compared to its predecessor, La...

    Waiting to Exhale
  • "I was diagnosed 21 years ago, and when you wait 21 years for something like an inhalable insulin, your hopes can get really high," says Cummings, who didn't expect to go off shots entirely (she would still need her once-daily, 16-unit injection of Lantu...

  • Irritable Bowel Videos -
    Basaglar Basaglar (insulin glargine) is a long-acting human insulin analog indicated to improve glycemic...

    1 2 3 4 5 6 7 8 9